Creative Medical Technology Holdings, Inc.
CELZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $6,838 | $4,298 | $3,815 |
| - Cash | $5,376 | $6,544 | $7,703 | $5,940 |
| + Debt | $0 | $0 | $14 | $14 |
| Enterprise Value | – | $294 | -$3,390 | -$2,112 |
| Revenue | $0 | $0 | $3 | $3 |
| % Growth | – | -100% | 0% | – |
| Gross Profit | $0 | -$31 | $2 | $2 |
| % Margin | – | – | 60% | 60% |
| EBITDA | -$1,205 | -$1,203 | -$1,630 | -$1,945 |
| % Margin | – | – | -54,330% | -64,823.3% |
| Net Income | -$1,236 | -$1,233 | -$1,638 | -$1,854 |
| % Margin | – | – | -54,603.2% | -61,802.5% |
| EPS Diluted | -0.48 | -0.48 | -0.83 | -1.12 |
| % Growth | 0% | 42.2% | 25.9% | – |
| Operating Cash Flow | -$1,169 | -$1,159 | -$1,592 | -$1,950 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1,169 | -$1,159 | -$1,592 | -$1,950 |